yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q37586729-25D16C7A-B48B-467D-AA7E-FF0B022F7193
Q37586729-25D16C7A-B48B-467D-AA7E-FF0B022F7193
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37586729-25D16C7A-B48B-467D-AA7E-FF0B022F7193
Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes
P2860
Q37586729-25D16C7A-B48B-467D-AA7E-FF0B022F7193
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37586729-25D16C7A-B48B-467D-AA7E-FF0B022F7193
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4ab1526380a895dd18ce374418736fabc8fa8501
P2860
Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes.